Listen to Oncology Here & Now
Dr. Elisa Agostinetto of the Jules Bordet Institute (Belgium) speaks with Dr. Maryam Lustberg of Yale Cancer Center about CDK4/6 inhibitors in the adjuvant treatment of breast cancer: abemaciclib and ribociclib following the monarchE and NATALEE trials, their use in male breast cancer, and more.
Prostate cancer statistics 2025Dr. Gil Morgan and Mr. Tyler KratzerSeason 2, Episode 2, September 25, 2025
The BULLSEYE trial and PSMA radioligandsDr. Danny Mena and Dr. Barbara MelãoSeason 2, Episode 1, September 7, 2025
Upper tract urothelial carcinomaDr. Philippe Spiess and Dr. Barbara MelãoSeason 1, Episode 6, May 20, 2025
Annual Report to the Nation on the Status of CancerDr. Gil Morgan and Dr. Ahmedin JemalSeason 1, Episode 5, April 28, 2025
First-line therapy in EGFR-mutant NSCLCDr. Marcelo Corassa and Dr. Biagio RicciutiSeason 1, Episode 4, April 14, 2025
Supportive care and telemedicineDr. Joseph McCollom and Dr. Cristiane BergerotSeason 1, Episode 3, March 26, 2025
